Delivery Order SPE2DR25D3501-SPE2DR26FM2TU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,100.64 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count unit dose packaging) with a completion date of January 9, 2026. This firm fixed-price, non-competitive delivery order was awarded on January 8, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TRIUMEQ 600-50-300 MG tablets (30-count units) with a ceiling value of $78,899.37. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This order, valued at $8,903.19, is issued under a firm fixed-price delivery order contract with an ultimate completion date of September 16, 2025. The award represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This delivery order, valued at $7,559.40 with a firm fixed price structure, represents a competitive award with no set-aside designation. The contract is scheduled for ultimate completion on June 3, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- This delivery order, valued at $15,313.29 with an ultimate completion date of April 29, 2025, awards AmerisourceBergen Drug Corp the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. The Defense Logistics Agency (DLA), through its Medical Supply Chain, issued this firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the place of performance for this award—serves as a critical...
- This delivery order, awarded August 12, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 30-count supplies of TRIUMEQ 600-50-300 mg tablets with a ceiling value of $55,079.80 under firm fixed-price terms. The award, which carries an ultimate completion date of August 13, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- This delivery order, awarded September 26, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, involves the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. The contract carries a ceiling value of $34.8K and utilizes firm fixed pricing with an ultimate completion date of September 29, 2025. The award was made without a set-aside designation, indicating open competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $6,870.93 on December 16, 2025, for the supply of Triumeq 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract completion date is set for December 17, 2025, with performance to occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $2,406.24 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by January 8, 2026, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRIUMEQ 600-50-300 MG TABLET in 30-count packages. The total ceiling value of the contract is $7,132.33, with a completion date of February 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2TUDelivery Order
This delivery order, awarded January 20, 2026, to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), calls for the supply of TRIUMEQ 600-50-300 mg tablets in 30-unit packages with a ceiling value of $7,268.82. The order is non-competitive and carries a firm fixed price structure with a completion deadline of January 21, 2026. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities—to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medications across multiple therapeutic domains to the Defense Health Agency and other federal healthcare systems through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 1/19/26 |